← Back to Search

Hybrid vs. Center-based Cardiac Rehabilitation for Cardiovascular Disease

N/A
Waitlist Available
Led By Pamela Tanguay
Research Sponsored by Université de Sherbrooke
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up questionnaire will be completed at 0 months, 3 months and 9 months
Awards & highlights

Study Summary

This trial hopes to compare the effectiveness of a hybrid vs. centre-based cardiac rehabilitation program in people with cardiovascular disease. Results will show if the hybrid model can better maintain long-term gains.

Who is the study for?
This trial is for adults over 19 with cardiovascular disease who are eligible for the Vitalité Health Network Cardiac rehabilitation program. It's not specified who can't join, so it may be open to many people.Check my eligibility
What is being tested?
The study compares a hybrid cardiac rehab program (partly at hospital, partly at home) with a traditional center-based one. The focus is on whether the hybrid approach better maintains health benefits six months post-rehab.See study design
What are the potential side effects?
Potential side effects aren't detailed in this summary, but generally, cardiac rehab programs might include muscle soreness or fatigue from exercise.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~questionnaire will be completed at 0 months, 3 months and 9 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and questionnaire will be completed at 0 months, 3 months and 9 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in level of Physical Activity
Secondary outcome measures
Change in anxiety and Depression
Change in functional Capacity
Change in health-Related Quality of Life

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Hybrid cardiac rehabilitation programExperimental Treatment1 Intervention
Group II: Center-based cardiac rehabilitation programActive Control1 Intervention

Find a Location

Who is running the clinical trial?

Université de SherbrookeLead Sponsor
292 Previous Clinical Trials
69,163 Total Patients Enrolled
Pamela TanguayPrincipal InvestigatorUniversité de Sherbrooke

Media Library

Center-based Cardiac Rehabilitation Intervention Clinical Trial Eligibility Overview. Trial Name: NCT05868343 — N/A
Cardiovascular Disease Research Study Groups: Center-based cardiac rehabilitation program, Hybrid cardiac rehabilitation program
Cardiovascular Disease Clinical Trial 2023: Center-based Cardiac Rehabilitation Intervention Highlights & Side Effects. Trial Name: NCT05868343 — N/A
Center-based Cardiac Rehabilitation Intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT05868343 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there various locations in this state conducting the clinical trial?

"This medical trial is presently welcoming participants from 9 different sites, such as Bouctouche, Campbellton and Caraquet. It may be helpful to choose the closest site in order to reduce travel commitments for those participating."

Answered by AI

What is the approximate number of individuals that are participating in this experiment?

"Affirmative, the information available on clinicaltrials.gov implies that this research study is recruiting participants as of now. Initially posted on May 1st 2023 and updated recently on May 19th 2023, this medical trial looks to include 278 people from 9 different locations."

Answered by AI

Are there still opportunities to be involved in this experiment?

"Per the clinicaltrials.gov website, this experiment is currently in need of participants. It was initially published on May 1st 2023 and has recently been revised as of May 19th 2023."

Answered by AI
~82 spots leftby Oct 2024